Diagnostica Stago STA N®oplastine® CI, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombin time (PT) in plasma. REF: 00666 The STA® - N®oplastine® CI kits provide reagents for the determination of the prothrombin time (PT) in plasma with STA-R®, STA Compact® and STA Satellite®. (In the USA this procedure has been assigned to the moderate complexity category per CLIA 1988 - CDC Analyte Code 4922; CDC Test System Codes 4677 and 4875).
Published September 19, 2018 · Recall initiated: July 24, 2018
Summary
FDA records medical device Class II recall Z-2994-2018, published September 19, 2018 and initiated July 24, 2018. Recalling firm: Diagnostica Stago, Inc.; Status: Terminated; Reported quantity: 5 kits; Lot: Lot Number/Exp. Date/UDI 251426 2018-11-30 (01)03607450006667(11)161130(17)181130(10)251426(241)00666; 251763 2019-02-28 (01)03607450006667(11)170228(17)190228(10)251763(241)00666. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
QC values outside of the assigned ranges (prolonged Prothrombin time / decreased PT %)
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Diagnostica Stago, Inc.
- Distributor
- Nationwide
- Lot
- Lot Number/Exp. Date/UDI 251426 2018-11-30 (01)03607450006667(11)161130(17)181130(10)251426(241)00666; 251763 2019-02-28 (01)03607450006667(11)170228(17)190228(10)251763(241)00666
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDASTA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitativeSeptember 9, 2026
- FDASTA-Liquid Anti-Xa 4. Model/Catalog Number: 00311US. The STA - Liquid Anti-Xa kits are intended for use withSeptember 3, 2025
- FDAAztlan Mole Oaxaqueno Negro; 10 kg plastic buckets (22 lbs); Ingredients: sugar, Ancho pepper, peanut, soybeanSeptember 19, 2018
- FDAEdwards Lifesciences Thin-Flex Single Stage Venous Drainage Cannula, 38FRX40CM, resterilized.September 19, 2018
- FDANeoplastine® Cl Plus ¿ (ref. 00375) Product Usage: Manual or automated determination of the prothrombin timeMarch 21, 2018
- FDASTA - Neoplastine® Cl Plus ¿ (ref. 00606) Product Usage: Manual or automated determination of the prothrombinMarch 21, 2018
Questions about this recall
Was Diagnostica Stago STA N®oplastine® CI, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombin time (PT) in plasma. REF: 00666 The STA® - N®oplastine® CI kits provide reagents for the determination of the prothrombin time (PT) in plasma with STA-R®, STA Compact® and STA Satellite®. (In the USA this procedure has been assigned to the moderate complexity category per CLIA 1988 - CDC Analyte Code 4922; CDC Test System Codes 4677 and 4875). recalled?
Yes. FDA published recall Z-2994-2018 on September 19, 2018. Reported hazard: QC values outside of the assigned ranges (prolonged Prothrombin time / decreased PT %)
What should I do if I have this product?
Voluntary: Firm initiated · Letter